D. E. Shaw & Co., Inc. Aeglea Bio Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.5 - $2.66 $11,155 - $59,347	22,311 Added 4.91%	476,404 $241,000
Q1 2022 May 16, 2022	BUY	$1.87 - $4.77 $423,713 - $1.08 Million	226,585 Added 99.59%	454,093 $1.05 Million
Q4 2021 Feb 14, 2022	BUY	$3.5 - $8.42 $696,517 - $1.68 Million	199,005 Added 698.19%	227,508 $1.08 Million
Q3 2021 Nov 15, 2021	SELL	$6.03 - $7.95 $105,392 - $138,950	-17,478 Reduced 38.01%	28,503 $227,000
Q2 2021 Aug 16, 2021	SELL	$6.32 - $8.38 $105,961 - $140,499	-16,766 Reduced 26.72%	45,981 $320,000
Q1 2021 May 17, 2021	SELL	$6.76 - $8.57 $331,158 - $419,827	-48,988 Reduced 43.84%	62,747 $497,000
Q4 2020 Feb 16, 2021	BUY	$7.02 - $9.83 $122,821 - $171,985	17,496 Added 18.57%	111,735 $879,000
Q3 2020 Nov 16, 2020	BUY	$6.51 - $9.33 $8,339 - $11,951	1,281 Added 1.38%	94,239 $669,000
Q2 2020 Aug 14, 2020	BUY	$4.01 - $11.04 $263,521 - $725,504	65,716 Added 241.23%	92,958 $860,000
Q1 2020 May 15, 2020	BUY	$3.51 - $8.48 $95,619 - $231,012	27,242 New	27,242 $127,000
Q3 2019 Nov 14, 2019	SELL	$6.42 - $9.0 $323,426 - $453,402	-50,378 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$6.1 - $8.78 $192,009 - $276,368	31,477 Added 166.54%	50,378 $345,000
Q1 2019 May 15, 2019	BUY	$7.6 - $9.4 $143,647 - $177,669	18,901 New	18,901 $152,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.